国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2009年
7期
657-658,661
,共3页
闫海润%金大伟%仝连信%姜蕾
閆海潤%金大偉%仝連信%薑蕾
염해윤%금대위%동련신%강뢰
胸水%腹水%芯片分析技术%肿瘤%生物学标记
胸水%腹水%芯片分析技術%腫瘤%生物學標記
흉수%복수%심편분석기술%종류%생물학표기
Hydrothorax%Ascites%Microchip Analytical Procedures%Neoplasms%Biological Markers
目的 探讨蛋白芯片技术检测多肿瘤标志物对良恶性胸腹水的鉴别诊断价值.方法 检测108例患者的胸腹水癌胚抗原(CEA)、甲胎蛋白(AFP)、癌抗原(CA125)、癌抗原(CA15-3)、糖链抗原(CA19-9)、糖链抗原(CA242)、前列腺特异性抗原(PSA、f-PSA)、神经元特异性烯醇化酶(NSE)、人绒毛膜促性腺激素(hCG、β-HCG)、生长激素(HGH)、铁蛋白(Ferritin、Fe)水平,对检测数据进行统计学分析.结果 良恶性组标本的胸腹水NSE、PSA/f-PSA比较差异无统计学意义(P>0.05),而另外9种肿瘤标志物比较差异有统计学意义(P<0.05).胸腹水多肿瘤标志物蛋白芯片检测系统在鉴别良恶性胸腹水诊断中的敏感性、特异性、准确性均高于常规检验.结论 检测胸腹水多肿瘤标志物有助于良恶性胸腹水鉴别诊断.
目的 探討蛋白芯片技術檢測多腫瘤標誌物對良噁性胸腹水的鑒彆診斷價值.方法 檢測108例患者的胸腹水癌胚抗原(CEA)、甲胎蛋白(AFP)、癌抗原(CA125)、癌抗原(CA15-3)、糖鏈抗原(CA19-9)、糖鏈抗原(CA242)、前列腺特異性抗原(PSA、f-PSA)、神經元特異性烯醇化酶(NSE)、人絨毛膜促性腺激素(hCG、β-HCG)、生長激素(HGH)、鐵蛋白(Ferritin、Fe)水平,對檢測數據進行統計學分析.結果 良噁性組標本的胸腹水NSE、PSA/f-PSA比較差異無統計學意義(P>0.05),而另外9種腫瘤標誌物比較差異有統計學意義(P<0.05).胸腹水多腫瘤標誌物蛋白芯片檢測繫統在鑒彆良噁性胸腹水診斷中的敏感性、特異性、準確性均高于常規檢驗.結論 檢測胸腹水多腫瘤標誌物有助于良噁性胸腹水鑒彆診斷.
목적 탐토단백심편기술검측다종류표지물대량악성흉복수적감별진단개치.방법 검측108례환자적흉복수암배항원(CEA)、갑태단백(AFP)、암항원(CA125)、암항원(CA15-3)、당련항원(CA19-9)、당련항원(CA242)、전렬선특이성항원(PSA、f-PSA)、신경원특이성희순화매(NSE)、인융모막촉성선격소(hCG、β-HCG)、생장격소(HGH)、철단백(Ferritin、Fe)수평,대검측수거진행통계학분석.결과 량악성조표본적흉복수NSE、PSA/f-PSA비교차이무통계학의의(P>0.05),이령외9충종류표지물비교차이유통계학의의(P<0.05).흉복수다종류표지물단백심편검측계통재감별량악성흉복수진단중적민감성、특이성、준학성균고우상규검험.결론 검측흉복수다종류표지물유조우량악성흉복수감별진단.
Objective To evaluate the clinical value of multiple tumor markers in differential diagnosis of benign and malignant hydrothorax and ascites by using protein chip technology. Methods The levels of 12 tumor markers, including carcinoembryonic antigen (CEA), alpha fetoprotein (AFP), CA125, CA15-3, carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 242 (CA242),prostate specific antigen (PSA, f-PSA), neurone specific enolase (NSE), human chorionic gonadotrophin (hCG, β-HCG), human growth hormone (HGH), ferroprotein (Ferritin, Fe), were measured in bydrothorax and ascites samples from 108 cases of patients, and the date were statistically analyzed.Results There were no significant differences in NSE and PSA/f-PSA levels in hydrothorax and ascites between the benign group and the malignant group (P>0.05), but there were in levels of other nine tumor markers (P<0.05). The sensitivity, specificity and accuracy of multiple tumor markers were significantly higher than those of routine test in differential diagnosis of benign and malignant hydrothorax and ascites. Conclusion The detection of multiple tumor markers contributes to differential diagnosis of benign and malignant hydrothorax and ascites.